Virbac SA engages in the manufacture and sale of veterinary medicines. The company is headquartered in Carros, Paca and currently employs 5,620 full-time employees. Its production centers are located in France, Australia, the United States, Mexico, Vietnam, Brazil and South Africa. Its development efforts focus mainly on formulating drugs designed to prevent or cure certain animal diseases. Its product portfolio encompasses pet medications such as pest control drugs, vaccines, antibiotics, anesthetics, anti-inflammatory drugs, mouth/dental care products, ophthalmologic and dermatological products intended for dogs, cats, horses, birds and rodents, as well as livestock medications including pest control drugs and antibiotics intended for cattle, sheep, pigs and poultry. The company also offers food and electronic identification chips for pets.
Follow-Up Questions
VRBCF hissesinin fiyat performansı nasıl?
VRBCF 'in mevcut fiyatı $0 'dir, son işlem günde 0% decreased etti.
Virbac SA için ana iş temaları veya sektörler nelerdir?
Virbac SA Pharmaceuticals endüstrisine ait ve sektör Health Care 'dir
Virbac SA 'in piyasa değerlemesi nedir?
Virbac SA 'in mevcut piyasa değerlemesi $0 'dir
Virbac SA al, sat, yoksa beklemeli mi?
Wall Street analistlerine göre, 12 analist Virbac SA için analist derecelendirmeleri gerçekleştirdi, bunlar 4 güçlü al, 7 al, 3 tut, 0 sat ve 4 güçlü sat içermektedir
